Skip to content
Home/Companies/Biotech/clock.bio
CB

clock.bio

Biotech·United Kingdom·Active·2yr hold

clock.bio is a biotech company, headquartered in United Kingdom.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns clock.bio?

clock.bio is currently owned by BlueYard Capital through BlueYard Capital Fund III (2022 vintage), since 2024.

Hand-verified · updated 2026-07-17

BlueYard Capital
Investor
BlueYard Capital
BlueYard Capital Fund III · 2022 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from BlueYard Capital Fund III

Other portfolio companies in the same fund.

Aerska
Active
BiotechIreland· 2025
Corintis
Active
Deep TechSwitzerland· 2025
Manex AI
Active
AI/MLGermany· 2025
Miren
Active
Cloud InfrastructureUnited States· 2025
ZeroPhase
Active
Aerospace & DefenceGermany· 2025
AnySignal
Active
Aerospace & DefenceUnited States· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings